Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition
PURPOSE
Children with pediatric gliomas harboring a BRAF V600E mutation have poor outcomes with current chemoradiotherapy strategies. Our aim was to study the role of targeted BRAF inhibition in these tumors.
PATIENTS AND METHODS
We collected clinical, imaging, molecular, and outcome information from patients with BRAF V600E–mutated glioma treated with BRAF inhibition across 29 centers from multiple countries.
RESULTS
Sixty-seven patients were treated with BRAF inhibition (pediatric low-grade gliomas [PLGGs], n = 56; pediatric high-grade gliomas [PHGGs], n = 11) for up to 5.6 years. Objective responses were observed in 80% of PLGGs, compared with 28% observed with conventional chemotherapy ( P < .001). These responses were rapid (median, 4 months) and sustained in 86% of tumors up to 5 years while receiving therapy. After discontinuation of BRAF inhibition, 76.5% (13 of 17) of patients with PLGG experienced rapid progression (median, 2.3 months). However, upon rechallenge with BRAF inhibition, 90% achieved an objective response. Poor prognostic factors in conventional therapies, such as concomitant homozygous deletion of CDKN2A, were not associated with lack of response to BRAF inhibition. In contrast, only 36% of those with PHGG responded to BRAF inhibition, with all but one tumor progressing within 18 months. In PLGG, responses translated to 3-year progression-free survival of 49.6% (95% CI, 35.3% to 69.5%) versus 29.8% (95% CI, 20% to 44.4%) for BRAF inhibition versus chemotherapy, respectively ( P = .02).
CONCLUSION
Use of BRAF inhibition results in robust and durable responses in BRAF V600E–mutated PLGG. Prospective studies are required to determine long-term survival and functional outcomes with BRAF inhibitor therapy in childhood gliomas.
Топ-30
Журналы
|
2
4
6
8
10
12
14
16
|
|
|
Frontiers in Oncology
16 публикаций, 16.84%
|
|
|
Neuro-Oncology
8 публикаций, 8.42%
|
|
|
Child's Nervous System
6 публикаций, 6.32%
|
|
|
Pediatric Blood and Cancer
5 публикаций, 5.26%
|
|
|
Cancers
4 публикации, 4.21%
|
|
|
Journal of Neuro-Oncology
3 публикации, 3.16%
|
|
|
Brain Sciences
3 публикации, 3.16%
|
|
|
Neuro-Oncology Advances
3 публикации, 3.16%
|
|
|
Cureus
2 публикации, 2.11%
|
|
|
Current Oncology
2 публикации, 2.11%
|
|
|
American Journal of Neuroradiology
2 публикации, 2.11%
|
|
|
Children
1 публикация, 1.05%
|
|
|
Frontiers in Ophthalmology
1 публикация, 1.05%
|
|
|
Neuroradiology
1 публикация, 1.05%
|
|
|
Scientific Reports
1 публикация, 1.05%
|
|
|
International Journal of Clinical Oncology
1 публикация, 1.05%
|
|
|
Acta Neurochirurgica
1 публикация, 1.05%
|
|
|
Molecular Imaging and Biology
1 публикация, 1.05%
|
|
|
BMC Pediatrics
1 публикация, 1.05%
|
|
|
International Journal of Radiation Oncology Biology Physics
1 публикация, 1.05%
|
|
|
Journal of Paediatrics and Child Health
1 публикация, 1.05%
|
|
|
British Journal of Clinical Pharmacology
1 публикация, 1.05%
|
|
|
Journal of the American Chemical Society
1 публикация, 1.05%
|
|
|
Journal of Clinical Oncology
1 публикация, 1.05%
|
|
|
Cell Reports Medicine
1 публикация, 1.05%
|
|
|
Pediatric Hematology/Oncology and Immunopathology
1 публикация, 1.05%
|
|
|
Genes
1 публикация, 1.05%
|
|
|
Nature Communications
1 публикация, 1.05%
|
|
|
Acta Neuropathologica
1 публикация, 1.05%
|
|
|
2
4
6
8
10
12
14
16
|
Издатели
|
5
10
15
20
25
30
|
|
|
Springer Nature
30 публикаций, 31.58%
|
|
|
Frontiers Media S.A.
17 публикаций, 17.89%
|
|
|
Oxford University Press
13 публикаций, 13.68%
|
|
|
MDPI
11 публикаций, 11.58%
|
|
|
Wiley
8 публикаций, 8.42%
|
|
|
Elsevier
7 публикаций, 7.37%
|
|
|
American Society of Clinical Oncology (ASCO)
2 публикации, 2.11%
|
|
|
American Society of Neuroradiology (ASNR)
2 публикации, 2.11%
|
|
|
American Chemical Society (ACS)
1 публикация, 1.05%
|
|
|
Fund Doctors, Innovations, Science for Children
1 публикация, 1.05%
|
|
|
Massachusetts Medical Society
1 публикация, 1.05%
|
|
|
Radiological Society of North America (RSNA)
1 публикация, 1.05%
|
|
|
IMR Press
1 публикация, 1.05%
|
|
|
5
10
15
20
25
30
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.